MDCO : Analysis & Opinions

  1. Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog

    December 15, 2014
    Alnylam (ALNY) announced a strategy for developing its RNAi therapeutics in three strategic therapeutic areas (STArs): genetic ...
  2. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
Trading Center